Anti-CD40 mAbs promote TAM transformation to the antitumor phenotype [104], and synergistic treatment with anti-CSF-1R antibodies stimulates the antitumor activities of TAMs and assists tumor remission [105]. The gene discussed is CSF1R; the disease is neoplasm.